Article Details
Retrieved on: 2023-12-01 22:14:43
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Both Amgen and Sanofi have successfully developed and marketed competing anti-PCSK9 monoclonal antibody therapies: Repatha® (Evolocumab, Amgen) v ...
Article found on: www.mondaq.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here